C Kevin Tang

Affiliations

  • at Aurinia Pharmaceuticals Inc. (AUPH), 2025-03-04
  • at Singular Genomics Systems Inc. (OMIC), 2025-02-28
  • at Tcr2 Therapeutics Inc. (TCRR), 2024-02-14
  • at Rain Oncology Inc. (RAIN), 2024-02-02
  • Large Shareholder, Director at Jounce Therapeutics Inc. (JNCE), 2023-05-05
  • Large Shareholder, Director at La Jolla Pharmaceutical Co (LJPC), 2022-08-25
  • Other at Aptevo Therapeutics Inc. (APVO), 2021-11-26
  • Chief Executive Officer at Odonate Therapeutics Inc. (ODT), 2021-11-19
  • Other at Heron Therapeutics Inc. (HRTX), 2021-02-16
  • Large Shareholder at Cyclacel Pharmaceuticals Inc. (CYCC), 2017-02-27
  • Large Shareholder at Mirati Therapeutics Inc. (MRTX), 2013-10-28
  • Large Shareholder, Director at Ardea Biosciences Inc. (RDEA), 2012-06-20
  • Large Shareholder, Other at Penwest Pharmaceuticals Co (PPCO), 2010-09-22
  • Large Shareholder at Vanda Pharmaceuticals Inc. (VNDA), 2010-01-19
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
AUPH $8.09 100,000 10,029,500 2025-03-04 Filing
AUPH $7.92 500,000 9,929,500 2025-03-04 Filing
AUPH $8.00 148,038 9,429,500 2025-03-04 Filing
AUPH $8.02 351,962 9,281,462 2025-03-03 Filing
AUPH $7.97 100,720 8,929,500 2025-03-03 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
RAIN $1.21 40,132 3,850,513 2023-12-18 Filing
RAIN $1.20 109,435 3,890,645 2023-12-15 Filing
RAIN $1.21 24,406 4,000,080 2023-12-14 Filing
LJPC $3.66 41,290 Large Shareholder, Director 9,607,934 2021-12-01 Filing
LJPC $3.76 136,255 Large Shareholder, Director 9,649,224 2021-12-01 Filing